Abemaciclib (Verzenio) reduced the risk of progression or death by 62% compared with placebo in patients with advanced ...

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival ...

Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now ...

Abemaciclib significantly prolonged PFS compared with placebo for patients with advanced dedifferentiated liposarcoma, ...

Treatment with CDK4/6 inhibitor led to nearly 10-month median PFS in placebo-controlled SA ...

Eli Lilly's Verzenio could offer the first targeted therapy for dedifferentiated liposarcoma (DDLPS), an aggressive cancer that usually needs to be treated with chemotherapy, according to the results ...

This patient's prognosis was relatively good because the size of his tumor was less than 10 cm, although he also had poor prognostic features, such as the deep location of the tumor and its high-grade ...

A new or growing lump under your skin can be a symptom of liposarcoma, a type of cancer that starts in fat cells. Although the lump may be nothing serious, it's a good idea to get it checked out by ...

Gastrointestinal stromal tumor (GIST) of the rectum and pararectal space: A French Sarcoma Group (FSG) retrospective review. Background: Our single-institution series, now including 53 metastatic MLS ...

Kevin Daly had no idea why he had a beer belly. “I don’t even like beer,” he told the New York Daily News. “I was lean. I’m 6’3” and very athletic.” The 63-year-old New Jersey resident didn’t have a ...